Compugen reported $4.11M in Trade Debtors for its fiscal quarter ending in June of 2026.





Trade Debtors Change Date
aTyr Pharma USD 883K 23K Jun/2026
Brainstorm Cell Therapeutics USD 122K 36K Mar/2026
Cara Therapeutics USD 2.24M 2.26M Mar/2025
Clal Biotechnology ILS 3.75M 186K Dec/2022
Compugen USD 4.11M 1.77M Jun/2026
Immunic USD 333K 156K Dec/2025
RedHill Biopharma USD 210K 70K Jun/2026
TherapeuticsMD USD 2.91M 310K Jun/2024